Neurometabolic effects of ACTH on free amino compounds in opsoclonus-myoclonus syndrome

Neuropediatrics

Volumn 39, Issue 3, 2008, Pages 164-171

  Pranzatelli, M R ^a   Tate, E D ^a   Crowley, J M ^b   Toennies, B ^c   Creer, M ^c,d  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c SSM Cardinal Glennon Children's Medical Center   (United States)

^d SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

Author keywords

ACTH; Ataxia; Dancing eyes; Immunotherapy; Neuroblastoma; Paraneoplastic syndrome

Indexed keywords

4 AMINOBUTYRIC ACID; ALANINE; AMINO ACID; AZATHIOPRINE; CORTICOSTEROID; CORTICOTROPIN; CYCLOPHOSPHAMIDE; GLUTAMINE; GLYCINE; H P ACTHAR GEL; IMMUNOGLOBULIN; LYSINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; ORNITHINE; PHENYLALANINE; PHOSPHOETHANOLAMINE; PREDNISOLONE; PREDNISONE; TAURINE; TYROSINE; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; ARTICLE; BRAIN METABOLISM; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG MECHANISM; DRUG MEGADOSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; NEUROTRANSMISSION; OPSOCLONUS MYOCLONUS SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL;

ADRENOCORTICOTROPIC HORMONE; ALANINE; AMINO ACIDS; ANALYSIS OF VARIANCE; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, GAS; CORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUTAMINE; HUMANS; IMMUNOTHERAPY; LYSINE; MALE; MASS SPECTROMETRY; OPSOCLONUS-MYOCLONUS SYNDROME; ORNITHINE; PHENYLALANINE; SEVERITY OF ILLNESS INDEX; TAURINE; TYROSINE;

EID: 57049152814     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1085466     Document Type: Article

References (43)

1. Airaksinen EM, Leino E. Decrease of GABA in the cerebrospinal fluid of patients with progressive myoclonus epilepsy and its correlation with the decrease of 5H1AA and HVA. Acta Neurol Scand 1982; 66: 666-672
2. Crawford PM, Lloyd KG, Chadwick DW. CSF gradients for amino acid neurotransmitters. J Neurol Neurosurg Psychiatry 1988; 51: 1193-1200
3. Dahlin M, Elfving A, Ungerstedt U et al. The ketogenic diet influences the levels of excitatory and inhibitory amino acids in the CSF in children with refractory epilepsy. Epilepsy Res 2005; 64: 115-125
4. Eriksson AS, O'Connor WT. Analysis of CSF amino acids in young patients with generalized refractory epilepsy during an add-on study with lamotrigine. Epilepsy Res 1999; 34: 75-83
5. Faull KF, DoAmaral JR, Berger PA et al. Mass spectrometric identification and selected ion monitoring quantitation of γ-aminobutyric acid (GABA) in human lumbar cerebrospinal fluid. J Neurochem 1978; 31: 1119-1122
6. Gerrits GP, Trijbels FJ, Monnens LA et al. Reference values for amino acids in cerebrospinal fluid of children determined using ion-exchange chromatography with fluorimetric detection. Clin Chim Acta 1989; 182: 271-280
7. Gillessen T, Budd SL, Lipton SA. Excitatory amino acid neurotoxicity. Adv Exp Med Biol 2002; 513: 3-40
8. Hogberg H, Thornberg E, Blennow M et al. Excitatory amino acids in the cerebrospinal fluid of asphyxiated infants: relationship to hypoxicischemic encephalopathy. Acta Paediatr 1993; 82: 925-929
9. A receptor-chloride ionophore complex in dissociated hippocampal pyramidal neurons of the rat. Anesthesiology 1993; 79: 781-788
10. Heyes MP, Saito K, Crowley JS et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurologic disease. Brain 1992; 115: 1249-1273
11. Horikoshi T, Asanuma A, Yanagisawa K. Taurine and β-alanine act both on GABA and glycine receptors in Xenopus oocyte injected with mouse brain messenger RNA. Mol Brain Res 1988; 10: 83-92
12. Kaakkola S, Marnela KM, Oja SS et al. Leukocyte glutamate dehydrogenase and CSF amino acids in late onset ataxias. Acta Neurol Scand 1990; 82: 225-229
13. Kinsbourne M. Myoclonic encephalopathy of infants. J Neurol Neurosurg Psychiatry 1962; 25: 221-276
14. Klein A, Schmitt B, Boltshauser E. Long-term outcome of ten children with opsoclonus-myoclonus syndrome. Eur J Pediatr 2007; 166: 359-363
15. Kornhuber ME, Kornhuber J, Kornhuber AW et al. Positive correlation between contamination by blood and amino acid levels in cerebrospinal fluid of the rat. Neurosci Lett 1986; 69: 212-215
16. Lee PLY, Slocum RH. A high-resolution method for amino acid analysis of physiologic fluids containing mixed disulfides. Clin Chem 1988; 34: 719-723
17. Levine J, Panchalingam K, Rapoport A et al. Increased cerebrospinal fluid glutamine levels in depressed patients. Biol Psychiatry 2000; 47: 586-593
18. Loscher W, Siemes H. Cerebrospinal fluid gamma-aminobutynic acid levels in children with different types of epilepsy: effect of anticonvulsant treatment. Epilepsia 1985; 26: 314-319
19. Mally J, Szalai G, Stone TW. Changes in the concentration of amino acids in serum and cerebrospinal fluid of patients with Parkinson's disease. J Neurol Sci 1997; 151: 159-162
20. MacGale EHF, Pye IF, Stonier C et al. Studies of the inter-relationship between cerebrospinal fluid and plasma amino acid concentrations in normal individuals. J Neurochem 1977; 29: 291-297
21. Nicoli F, Vion-Dury J, Confort-Gouny S et al. Cerebrospinal fluid metabolic profiles in multiple sclerosis and degenerative dementias obtained by high resolution proton magnetic resonance spectroscopy. C R Acad Sci III 1996; 319: 623-631
22. Vivian ES. Amino acid analysis. In: Physician's Guide to the Laboratory Diagnosis of Metabolic Diseases 2nd edition, (Blau N, Duran M, Blaskovics ME, Gibson KM, eds.) Springer Verlag, New York; 2003: 11-26
23. Pranzatelli MR. On the molecular mechanism of adrenocorticotrophic hormone: neurotransmitters and receptors. Exp Neurol 1994; 125: 142-161
24. Pranzatelli MR. The pharmacology of antimyoclonic drugs. Clin Neurosci 1996; 3: 246-252
25. Pranzatelli MR. The immunopharmacology of the opsoclonus-myoclonus syndrome. Clin Neuropharmacol 1996; 19: 1-47
26. Pranzatelli MR. Opsoclonus-myodonus-ataxia. In: Fernandez-Alvarez E, Arzimanoglou A, Tolosa E, eds, Pediatric Movement Disorders. John Libbey Eurotext Limited, Montrouge, France; 2005; 121-136
27. Pranzatelli MR, Huang YY, Tate E et al. Monoaminergic effects of high-dose corticotropin in corticotropin-responsive pediatric opsoclonus-myoclonus. Mov Disord 1998; 13: 522-528
28. Pranzatelli MR, Tate ED, Galvan I et al. A controlled pilot study of piracetam for pediatric opsoclonus-myoclonus. Clin Neuropharmacol 2001; 24: 352-357
29. Pranzatelli MR, Travelstead AL, Tate ED et al. B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes. Neurology 2004: 62: 1526-1532
30. Rating D, Siemes H, Loscher W. Low CSF GABA concentration with febrile convulsions, untreated epilepsy, and meningitis. J Neurol 1983; 230: 217-225
31. Ross BM, Moszczynska A, Blusztajn JK et al. Phospholipid biosynthetic enzymes in human brain. Lipids 1997; 32: 351-358
32. Rothrock JF, Mar KR, Yaksh TL et al. Cerebrospinal fluid analyses in migraine patients and controls. Cephalalgia 1995; 15: 489-493
33. Schaff JM, Teelken AW, Muskiet FAJ et al. The specific and sensitive determination of gamma aminobutyric acid in CSF and brain tissue by gas chromatography mass spectrometry. J Neurosci Meth 1985; 13: 257-265
34. Shen EY, Lai YJ, Ho CS et al. Exciratory and inhibitory amino acid levels in the cerebrospinal fluids ofchildren with neurological disorders. Acta Paediatr Taiwan 1999; 40: 65-69
35. Smith I, White PF, Nathanson M et al. Propofol: An update on its clinical use. Anesthesiology 1994; 81: 1005
36. Smith SV, Forman DT. Laboratory analysis of cerebrospinal fluid. Clin Lab Sci 1994; 7: 32-38
37. Solomon GE, Chutorian AM. Opsoclonus and occult neuroblastoma. N Engl J Med 1968; 279: 475-477
38. Stover JF, Pleines UE, Morganti-Kossmann MC et al. Neurotransmitters in cerebrospinal fluid reflect pathological activity. Eur J Clin Invest 1997: 27: 1038-1043
39. Takahashi K. Studies on free amino acid patterns in cerebrospinal fluid of children. Part 1. The individuality of the free amino acid patterns in cerebrospinal fluid. Acta Paediatr Jpn 1978; 20: 11-23
40. Tate ED, Pranzatelli MR, Huang Yy et al. An innovative approach to problem of sedating children with opsoclonus-myoclonus syndrome: effects on myoclonus and CSF monoamine metabolites. Ann Neurol 1994; 36: A609
41. Tatro JB. Melanotropin receptors in the brain are differentially distributed and recognize both corticotropin and alpha-melanocyte stimulating hormone. Brain Res 1990; 536: 124-132
42. Hemelrijck J Van, White PF. Nonopioid intravenous anesthesia. In: Barash PG, Cullen BF, Stoelting RK, eds, Clinical Anesthesia. Lippincott-Raven Publishers, Philadelphia; 1996; 311-327
43. Xiang J, Ennis SR, Abdelkarim GE et al. Glutamine transport at the blood-brain and blood-cerebrospinal fluid barriers. Neurochem Int 2003; 43: 279-288